drugset / Trial / NCT00938548

Perioperative Administration of Pregabalin for Pain After Mastectomy

NCT00938548

Phase 4 Completed 70 enrolled Severance Hospital
RandomizedParallel-groupTriple-blindTreatment

Summary

The investigators hypothesize that pregabalin will decrease post-operative pain scores and analgesic use following total mastectomy compared to placebo. The primary outcome will be acute postoperative pain, measured by a verbal numerical rating score (VNRS) and total analgesic consumption during postoperative 48 hours. The secondary outcome will be VNRS at 1 week and 1 month after operation.

Timeline

Start
2009-06
Primary completion
2009-12
Completion
2010-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Pregabalin Small molecule 75 mg Oral

Indications